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Abstract
Background: Sexual transmitted infections (STIs) have increased in Germany and other countries in Europe since the 
mid-nineties. To obtain a better picture of diagnostic methods used in STI testing institutions in Germany, we 
performed a nationwide survey amongst STI specialists in order to evaluate the quality of STI reports and provide 
recommendations to harmonize and possibly improve STI diagnostics in Germany.
Methods: We asked sentinel physicians and randomly chosen gynaecologists, urologists and dermato-venerologists, 
about the diagnostic methods used in 2005 to diagnose HIV, chlamydia (CT), gonorrhoea (GO) and syphilis (SY) in a 
national cross-sectional survey in order to recognize potential problems and provide recommendations.
Results: A total of 739/2287 (32%) physicians participated. Of all participants, 80% offered tests for HIV, 84% for CT, 83% 
for GO and 83% for SY. Of all participants who performed HIV testing, 90% requested an antibody test, 3% a rapid test 
and 1% a nucleic acid amplification test (NAAT). For CT testing, NAAT was used in 33% and rapid tests in 34% of 
participants. GO resistance testing was performed by 31% of the participants. SY testing was performed in 98% by 
serology.
Conclusions: Diagnostic methods for STI vary highly among the participants. Diagnostic guidelines should be 
reviewed and harmonised to ensure consistent use of the optimal STI diagnostic methods.
Background
Most sexual transmitted infections (STIs) have increased
in Germany and other countries in Europe in the mid-
nineties [1-3], rising fears of subsequent increased HIV
transmission. However, in the last couple of years not all
STIs showed a similar epidemiology: While the number
of new HIV and syphilis infections still rose in the last
years [4-6], the number of newly diagnosed gonorrhoea
infections declined in Europe [3]. Early detection and
treatment are very important methods to control the
transmission of STIs [7]. Since 2001, syphilis and HIV are
the only notifiable STIs in Germany. Further data for STIs
are collected through a sentinel surveillance system put
in place in 2002 [8]. Thus, data for STIs such as HIV,
syphilis, chlamydia, gonorrhoea and trichomoniasis is
being collected from approximately 250 selected institu-
tions nationwide. However, sentinel sites seemed to
employ a variety of laboratory methods.
To obtain a better picture of diagnostic methods used
in STI testing institutions in Germany, we performed a
nationwide survey amongst the sentinel participants and
other practicing STI specialists. This information will be
used to evaluate the quality of STI reports and provide
recommendations to harmonize and possibly improve
STI diagnostics in Germany.
Methods
We performed a national cross-sectional study. The study
population included all sentinel sites (local health offices,
hospital based STI clinics and private practitioners) par-
ticipating in the STI sentinel surveillance plus randomly
chosen private practitioners specialising in gynaecology,
urology, or dermato-venerology. Lists of practitioners
available from the state chambers of physicians were used
for the random selection. We calculated the required
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sample size with StatCalc, EpiInfo6, with focus on the
diagnosis on chlamydia. Assuming that 30% of the partic-
ipants would employ NAAT for chlamydia testing this led
to a calculated sample size requiring 620 participants. We
expected a response of approximately one third of the
contacted practitioners.
We developed a self-administered standardized ques-
tionnaire, with mainly closed questions, which was pre-
tested before use. The questionnaire covered the different
laboratory methods used for the detection of HIV, syphi-
lis, chlamydia, gonorrhoea and trichimoniasis. We also
asked information on the kind of samples taken (vaginal
swab, urine, blood) and if asymptomatic patients were
also tested for chlamydia, gonorrhoea or syphilis. In addi-
tion, the participants needed to provide the number and
demographic characteristics of patients they see, as well
as specify their type of catchment area (small or middle-
sized cities, metropolitan etc).
In the first months of 2006 we asked sentinel sites and
private practitioners to complete the questionnaire on
laboratory methods used in the year 2005. This included
both tests being performed in their own lab or sent away
to external labs.
The laboratory methods and testing strategies for the
following STIs were included in the questionnaire (see
additional file 1), multiple answers were possible:
• HIV: Antibody test, rapid-test
• Chlamydia: Rapid test, DNA probe, nucleic acid
amplification test (NAAT), antibody test; testing of
asymptomatic patients
• Gonorrhoea: Microscopy, NAAT, DNA probe, cul-
ture; resistance patterns, testing of asymptomatic
patients
• Trichimoniasis: Microscopy, culture
• Syphilis: Direct testing, dark field microscopy, serol-
ogy; testing of asymptomatic patients
No further details on the specific tests were collected.
The completed questionnaires were entered into an MS
Access database and analysed with EpiInfo 3.2.2. The
results were stratified by medical speciality
Results
Of 2287 contacted institutions and practitioners, 739
(32%) returned a questionnaire. Within the sentinel sur-
veillance institutions, the response rate was 56%, while
30% of the randomly selected private practitioners
responded.
A comparison between the sentinel and non-sentinel
institutions participating did not show any major differ-
ences regarding the used diagnostic methods. Therefore,
results are presented here not stratified by sentinel sys-
tem participation.
In total, 219 dermato-venerologists, 355 gynaecolo-
gists, 85 urologists and 48 public health offices replied, 32
participants did not specify their specialisation. Fifty-two
percent of the participants were situated in a metropoli-
tan catchment area, 38% working in small or middle-
sized cities. Participants replied from all federal states of
Germany.
Chlamydia testing was offered by 621 participants
(84%), followed by testing for syphilis (83%) and gonor-
rhoea (83%). Tests for HIV and trichimoniasis were
offered by 592 (80%) participants and 575 (77%) respec-
tively.
The proportions of participants testing for the different
STIs, stratified by medical speciality, can be seen in Table
1.
HIV
Of all participants who reported testing for HIV, 89%
used antibody tests, 3% a rapid test and 1% NAAT. The
remaining participants did not disclose the detection
methods used. There were no differences between differ-
ent medical specialisations.
Chlamydia
The proportions of the different detection methods for
chlamydia, stratified by medical speciality, are shown in
Table 2.
Cervical swabs were the most frequently used samples
for testing chlamydia (this varied depending on the
method, median 77%). While gynaecologists relied
almost exclusively on cervical samples (95%), urethral
Table 1: Proportions of participants testing for the different STIs in Germany in 2005, by medical speciality.
Dermato-Venerology Urology Gynaecology Public health offices
n = 219 n = 85 n = 335 n = 48
%%%%
HIV 76 65 85 94
Chlamydia 72 84 95 67
Gonorrhoea 94 87 77 75
Trichonomas 63 79 95 44
Syphilis 90 68 82 92Gilsdorf et al. BMC Infectious Diseases 2010, 10:98
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swabs were preferred by dermato-venerologists and urol-
ogists (89% resp. 81%).
Gonorrhoea
For the detection of gonorrhoea, microscopy (64%) and
culture (60%) were the most frequently used diagnostic
tools.
Dermato-venerologists used microscopy 91% of the
time, culture 56%. Gynaecologists performed cultures on
65% of samples and microscopy on 41%.
Samples for gonorrhoea examination were mainly ure-
thral swabs (76%) followed by cervical swabs. Gynaecolo-
gists preferred cervical swabs (93%). Dermato-
venerologists also performed regularly anal swabs (49%).
Testing for antimicrobial resistance was requested by
30% of the participants. Urologists most frequently
requested resistance testing (47%), followed by gynaecol-
ogists (33%).
Trichimoniasis
Trichimoniasis were examined in 94% of the participants
by microscopy and in 22% with culture. There were no
differences between the specialisations.
Syphilis
Serology was used by 98% of the responding participants
to look for syphilis. Serology was also used for confirma-
tory tests, to determine whether treatment is needed and
for follow up. However, when asked for the different types
of serological tests, participants' responses varied a lot.
Eighteen point three percent of participants used dark
field microscopy to identify syphilis, among dermato-
venerologists this technique was frequent (42%). There
were no further differences between the medical speciali-
sations.
Asymptomatic patients
Asymptomatic patients were tested for Chlamydia and
syphilis by 65% and 65% of the participants, respectively.
Antenatal screening was the main reason for these tests.
Also, 33% of the participants reported testing of asymp-
tomatic patients for gonorrhoea, giving "infection in the
patient's partner" or "sexual risk behaviour" (unprotected
sex or frequent changing of sex partners) as the main rea-
sons for testing (Table 3).
Discussion
The results show that STI diagnostic methods varied a lot
among the participants all over Germany. In addition,
STI detection methods varied substantially between the
different medical specialists. Antimicrobial resistance
testing and testing of asymptomatic patients also differed
considerably between participants. This could be seen
also for sample materials; however a lot of this variation is
self-evident, as the different specialists take mainly sam-
ples relevant for their work field (e.g. gynaecologists -
vaginal swabs, urologists - urethral swabs).
The overall response rate was with 32% as expected.
However the low percentage might have influenced the
results, as it is possible that practitioners who responded
to the survey are generally more aware of STIs and there-
fore more likely to offer comprehensive STI testing and
adhere to testing guidelines. In reality, it is possible that
fewer practitioners might offer STI testing and the test
methods used may be even more diverse than shown by
this survey. As participants did not perform all the testing
themselves, but also used external laboratories, details on
the reported used methods might be imprecise. However,
we believe that the specialists mainly could give a good
picture of the used methods.
HIV
Nearly all participants used the same recommended test
scheme for HIV [9], an Elisa screening test with sensitiv-
ity higher than 99%, followed by a Western blot as a con-
firmatory test with high specificity [10]:. But rapid tests
become more relevant as it reflects on the strong wish of
patients to have the results ready on the same day [10].
Table 2: Proportions of the different detection methods for chlamydia used in Germany in 2005, by medical speciality.
All Dermato-
Venerology
Urology Gynaecology Public health
offices
n = 621* n = 159 n = 71 n = 337 n = 32
% %%%%
Rapid test 34 44 17 48 6
DNA probe 25 22 34 26 16
NAAT (e.g. PCR) 33 34 38 29 56
Antigen test 26 26 25 28 13
Serology 26 38 31 19 16
Others 1 1313
*Difference in overall sum due to lacking information of speciality of 22 participants testing on ChlamydiaGilsdorf et al. BMC Infectious Diseases 2010, 10:98
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Chlamydia
The best diagnostic method for chlamydia is NAAT [11]
because of the high sensitivity (90-95%) and specificity
(up to 100%), even though the appearance of a new vari-
ant of Chlamydia trachomatis challenged the NAAT test
methods[12]. Our survey showed that only public health
offices widely used NAAT.
Most participants followed the current recommenda-
tions [11] regarding sampling for chlamydia testing and
took cervical or urethral swabs. Studies [13,14] showed
that the first morning urine from men or self-collected
vaginal swabs from women also provide good test results.
In addition, these collection methods are less invasive,
require less equipment and are well accepted by patients.
However, the participants seldom requested these sam-
ples of the patients. Clinical practitioners need to be
more widely informed on the advantages of using them.
The DNA probe test requires less complex transport,
and is cheaper than NAAT, but is also less sensitive (60-
80%) and specific (99.5%) [11,14]. In settings with few
resources or those unable to access transport facilities,
the DNA probe could be preferred.
Rapid tests for chlamydia, which show results within a
very short time and require little technical effort, were
used frequently. However, some studies show a consider-
ably lower sensitivity and specificity compared to tradi-
tional detecting methods [11,15]. So the use of rapid tests
cannot currently be recommended for routine diagnosis
of chlamydia [15], but may be of use in environments
with a population at high risk for the disease and where
immediate treatment is preferable because of unlikely fol-
low-up [10].
Serological testing for specific antibodies is not recom-
mended for detection of acute uro-genital chlamydia
infections, as many infections do not lead to a serological
response [16]. However, it might be a useful tool to diag-
nose chlamydia-associated secondary complications in
the absence of chlamydia symptoms, such as tubar steril-
ity, reactive arthritis or Reiter-syndrome.
Since 2008, chlamydia screening has been introduced
in Germany for a certain age group: all women under 25
years of age are offered a chlamydia test when visiting a
gynaecologist [17]. Pooled urine samples are tested using
NAAT. Though the use of pooled samples in the context
of screening is perhaps controversial, this programme
allows for the detection and treatment of asymptomatic
infections in a higher proportion of young women than
previously.
But women over the age of 25 years also need access to
reliable methods for diagnosing chlamydia infections, as
up to 80% of infections in these women are asymptomatic
[18] and can lead to severe complications if untreated.
Therefore, chlamydia testing using NAAT should be cov-
ered by all health insurances, regardless of the age of the
patient.
Gonorrhoea
Microscopy and culture are still the recommended
method for the detection of gonorrhoea [19-21], even
though NAAT is more sensitive [14,20], and could be
used to detect different agents in the same reaction in
urine specimens [22]. But N. gonorrhoeae species contin-
ues to present a considerable challenge for molecular
diagnostics [21] and does not allow resistance testing. As
antimicrobial resistance has increased recently [23,24],
resistance testing on gonorrhoea isolates is recom-
mended [21]. The number of participants performing
antimicrobial resistance testing in our study was clearly
inadequate, which raises concerns as infections with anti-
biotic-resistant strains will remain undetected, allowing
s p r e a d  o f  i n f e c t i o n s  c a u s e d  b y  a n t i m i c r o b i a l - r e s i s t a n t
gonorrhoea.
Trichimoniasis
The most common and recommended method for detec-
tion of trichimoniasis is microscopy [25]. This is reflected
in our results. Microscopy shows immediate but slightly
unreliable results with sensitivity varying between 36 and
80% [14]. Culture before microscopy can increase the
Table 3: Reasons for testing asymptomatic patients for chlamydia, gonorrhoea and syphilis, Germany 2005.





68 18 71 38 47 13
Antenatal care 205 53 18 10 170 45
Unspecific 
fluor
1 0 274- -
S k i n  d i s e a s e s ----3 8 1 0
Risk behaviour 31 8 44 23 63 17
Others 73 19 48 25 58 15Gilsdorf et al. BMC Infectious Diseases 2010, 10:98
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sensitivity [19]. Until NAAT for Trichimonas vaginalis is
commercially availably, a stepwise approach using an
additional rapid test for microscopy-negative women
should be considered for adolescent women regardless of
clinical factors [25].
Syphilis
A vast majority of the participants used serological tests
for the different levels of syphilis diagnosis. However, test
methods were not used consistently. The availability of
various diagnostic methods using different serological
markers led to high variety in testing. NAAT methods
became more relevant in recent years and can be used for
diagnostic of primary syphilis in STI outpatient clinics
and by general practitioners, but have no value for the
diagnostic of secondary syphilis [26]. Clearer guidelines
indicating the tests which should be used for different
purposes are necessary to harmonize the diagnostics of
syphilis in Germany.
Asymptomatic patients
A high percentage of participants also offered syphilis
and chlamydia testing for asymptomatic patients. Most of
these tests were performed during mandatory antenatal
screening. The guidelines regarding medical care during
pregnancy [27], formulated by the German Federal Joint
Committee require a pooled urine test for chlamydia and
a serology test for syphilis during the first visits to a
gynaecologist during pregnancy. Outside of antenatal
care asymptomatic tests should be offered especially to
persons reporting frequent changing of sexual partners
or unprotected sexual contact.
Monitoring diagnostic trends
Monitoring trends in the use of diagnostic methods
enhances STI control efforts by improving the interpreta-
tion of STI trends, creating valuable partnerships with
laboratories, facilitating the evaluation of screening pro-
grams and investigating outbreaks [28]. With the contin-
uous development and improvement of diagnostic
methods it is obvious that there have been changes since
this survey was performed. But even though the pre-
sented results give a picture of the used methods in 2005,
i t  i s  a  r e l e v a n t  s t e p  f o r  a  b e t t e r  u n d e r s t a n d i n g  o f  t h e
changes that STI diagnostics are undergoing and its rele-
vance for the interpretation of STI surveillance data.
Conclusions
Our results showed dramatically inconsistent use of STI
diagnostic methods across Germany. These methods
should be harmonised to ensure comparable, high quality
STI testing. Physicians require evidence-based informa-
tion on the strengths and weaknesses of different diag-
nostic methods which will allow them to make an
informed choice of the most appropriate tests, to cor-
rectly evaluate the results and therefore optimise treat-
ment.
To achieve this, education on current standard diagnos-
tic tools should be part of continuous professional educa-
tion. Additionally, the physicians should be provided with
harmonized, regularly updated guidelines from STI asso-
ciations to ensure reliable, coordinated and high quality
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